Unique Wealth Strategies’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$832K Hold
3,306
– – 0.31% 80
2026
Q2
$832K Buy
3,306
+596
+22% +$128K 0.3% 81
2026
Q1
$589K Sell
2,710
-52
-2% -$11.5K 0.24% 114
2025
Q4
$631K Buy
+2,762
New +$629K 0.25% 113
2025
Q3
– Sell
-3,337
Closed -$619K – 212
2025
Q2
$619K Buy
+3,337
New +$620K 0.26% 105
2024
Q3
– Sell
-2,637
Closed -$480K – 202
2024
Q2
$480K Hold
2,637
– – 0.23% 129
2024
Q1
$480K Buy
+2,637
New +$454K 0.24% 129

Other funds holding ABBV

Unique Wealth Strategies's ABBV Position: Q3 2026 in Review

Unique Wealth Strategies held its AbbVie (ABBV) position steady in Q3 2026 at 3,306 shares worth $832K. The position accounts for 0.31% of the portfolio, ranked #80.

Unique Wealth Strategies first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Unique Wealth Strategies held 3,306 shares of AbbVie worth $832K as of Q3 2026.
  • Unique Wealth Strategies left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.31% of Unique Wealth Strategies's portfolio in Q3 2026, its #80 holding.
  • Unique Wealth Strategies first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Unique Wealth Strategies's 13F filing for Q3 2026, filed 13 Oct 2026.